Mastek's Marilyn Jones ceases as independent director on Sep 4

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Marilyn Jones ceases as Independent Director on September 4, 2026
  • Departure follows completion of her tenure at Mastek Limited
  • Board appreciates her contributions and guidance during her term
  • Disclosure made under Regulation 30 of SEBI Listing Regulations
powered bylight_fuzz_icon
50071277

*this image is generated using AI for illustrative purposes only.

Mastek Limited announced that Ms. Marilyn Jones has ceased to be an Independent Director of the company with effect from September 4, 2026.

The departure follows the completion of her tenure as an Independent Director. The cessation took effect at close of business hours on September 4, 2026.

Board Appreciation

The Board of Directors and Management expressed deep appreciation for Ms. Jones' contributions, guidance, and services rendered during her tenure.

Regulatory Disclosure

The company made this disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. The filing references SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Reena Abhijit Raje, Company Secretary & Compliance Officer, signed the communication addressed to the Listing Departments of BSE Limited and The National Stock Exchange of India Limited.

Historical Stock Returns for Mastek

1 Day5 Days1 Month6 Months1 Year5 Years
-1.10%+10.01%-6.35%+13.73%-31.21%-36.63%

Has Mastek identified a successor for Ms. Marilyn Jones, and what is the expected timeline for appointing a new Independent Director?

How might the change in board composition impact Mastek's strategic decision-making or corporate governance structure in the short term?

Are there any pending regulatory approvals or shareholder meetings required to formalize the transition of board membership?

Mastek reschedules Sept 1 investor meet to 2:15 pm with Anand Rathi

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Mastek holds single investor meet on September 1, 2026
  • Interaction scheduled for 2:15 pm in Mumbai
  • Partner is Anand Rathi Share and Stock Brokers Ltd.
  • No UPSI to be shared during the one-to-one session
powered bylight_fuzz_icon
49302790

*this image is generated using AI for illustrative purposes only.

Mastek has updated the schedule for its upcoming investor meeting on September 1, 2026. The company will now hold a single investor interaction with Anand Rathi Share and Stock Brokers Ltd. at 2:15 pm in Mumbai, replacing the previously announced group dialogue.

Revised meet details

The earlier announcement indicated that Mastek would participate in the Ashwamedh - Elara India Dialogue 2026 as part of a group investor meet starting at 9:00 am. The new filing clarifies that the engagement is now a one-to-one interaction scheduled for the afternoon slot.

Parameter Previous Details Updated Details
Date September 1, 2026 September 1, 2026
Counterparty Ashwamedh - Elara India Dialogue Anand Rathi Share and Stock Brokers Ltd.
Nature of meet Group Investor Meet Single Investor Meet
Timing 9:00 am 2:15 pm
Venue/Mode Mumbai / In-Person Mumbai / In-Person

Compliance and disclosure

The interaction is governed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mastek has confirmed that discussions will be based on publicly available information regarding industry and company-specific developments. No unpublished price sensitive information (UPSI) is proposed to be shared during the meet. The intimation was filed on August 31, 2026, and hosted on the company's website.

Historical Stock Returns for Mastek

1 Day5 Days1 Month6 Months1 Year5 Years
-1.10%+10.01%-6.35%+13.73%-31.21%-36.63%

How might the shift from a group dialogue to a one-to-one meeting with Anand Rathi influence the depth and specificity of insights shared regarding Mastek's strategic roadmap?

What does the change in counterparty suggest about Mastek's current investor relations strategy or targeted market segments for 2026?

Could this scheduling adjustment indicate any internal operational changes or shifts in management availability that investors should monitor?

More News on Mastek

1 Year Returns:-31.21%